GO306 / GeneSail Biotech - LARVOL DELTA

A Clinical Study of GO306 in Patients With Advanced Solid Tumors (clinicaltrials.gov) - P1 | N=32 | Recruiting | Sponsor: GeneSail Biotech (Shanghai) Co., Ltd.

New P1 trial • Tumor mutational burden • Oncology • Solid Tumor • PD-L1

To evaluate the safety, tolerability and preliminary efficacy of GO306 recombinant oncolytic vaccinia virus injection in patients with advanced refractory solid tumors (ChiCTR) - P1 | N=32 | Not yet recruiting | Sponsor: The first affiliated hospital of anhui medical university; The first affiliated hospital of anhui medical university

New P1 trial • Breast Cancer • Colorectal Cancer • Gastrointestinal Cancer • Ovarian Cancer • Renal Cell Carcinoma • Small Cell Lung Cancer • Solid Tumor • Triple Negative Breast Cancer • BRCA • MSI